Tag: oncology
May 23, 2018
Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO
The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 22, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent
Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018
Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... May 13, 2018
5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent
Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018
Medicenna Receives Amendment to Revamp Clinical Trial
The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co.... May 10, 2018
Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and... May 10, 2018
BeiGene Reports First Quarter 2018 Financial Results
BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment... May 9, 2018
Dynavax Reports First Quarter 2018 Financial Results
Dynavax Technologies (NASDAQ:DVAX) today reported financial results for the first quarter ended March 31, 2018. The net loss for the... May 9, 2018
Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
Kura Oncology (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter... May 9, 2018
